Erol Arslan

Erol Arslan

Auto-generated profile, based on publicly available information

Erol Arslan

Istanbul Medipol Üniversitesi

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Genes & Cancer
Verified
Journal Article
Closed access
MKM. Karsy
M. Karsy
EAE. Arslan
E. Arslan
FMF. Moy
F. Moy
Glioblastoma multiforme (GBM) is an aggressive grade IV astrocytoma with a 1-year median survival rate despite current treatment modalities. A thorough understanding of the vast genetic aberrations and signaling pathways involved in gliomagenesis as well as heterogeneous clinicopathological presentation remains elusive. The recent discovery of microRNAs (miRs) and their capability of simultaneously regulating multiple downstream genes may play a key role in explaining the complex mechanisms underlying GBM formation. miRs are 19 to 25 nucleotide non-protein-coding small RNA molecules involved in the suppression of mRNA translation. This review will summarize and discuss the most recent findings regarding miRs in GBM including downstream targets, functional effects, and therapeutic potentials. Specifically discussed miRs include miR-7, miR-9/miR-9*, miR-10a/miR-10a*/miR-10b, miR-15b, miR-17-92, miR-21, miR-26a, miR-34a, miR-93, miR-101, miR-124, miR-125a, miR-125b, miR-128, miR-137, miR-146b-5p, miR-153, miR-181a/miR-181b, miR-196a/miR-196b, miR-218, miR-221/miR-222, miR-296, miR-302-367, miR-326, miR-381, miR-451, and let-7a. In addition to gene regulatory roles, miRs have demonstrated significant diagnostic, prognostic, and therapeutic potential. These small molecules may both help in the understanding of GBM and in developing new therapeutic options.

1 January 2012 in Folia Neuropathologica
Verified
Journal Article
Open access
MKMichael Karsy
Michael Karsy
MGMarshall Gelbman
Marshall Gelbman
PSPaarth Shah
Paarth Shah
OBOdessa Balumbu
Odessa Balumbu
FMFred Moy
Fred Moy
EAErol Arslan
Erol Arslan
Since the recent publication of the World Health Organization brain tumour classification guidelines in 2007, a significant expansion in the molecular understanding of glioblastoma multiforme (GBM) and its pathological as well as genomic variants has been evident. The purpose of this review...

15 December 2012 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
SBSamir N. Babayev
Samir N. Babayev
EAErol Arslan
Erol Arslan
SKStanley Kogan
Stanley Kogan
FMFred Moy
Fred Moy
KOKutluk Oktay
Kutluk Oktay

1 April 2020 in Best Practice & Research Clinical Obstetrics & Gynaecology
Verified
Journal Article
Closed access
EAErol Arslan
Erol Arslan
DBD. Ware Branch
D. Ware Branch

30 June 2019 in Cukurova Medical Journal
Verified
Journal Article
Open access
PDF file
MYMahmut Yassa
Mahmut Yassa
EAErol Arslan
Erol Arslan
DGDuru Saygin Gulbahar
Duru Saygin Gulbahar
Purpose: In this study, we aimed to show the most related factors with women's anxiety and depression levels as well find out the differences between primary and secondary infertile women with unexplained reason. Materials and Methods: This was a prospective controlled study of 166 primary and 60 secondary infertile women. They had unexplained infertility and had not any hormonal or uterine pathology. Beck Depression Inventory and Hamilton Anxiety Rating Scale were used for questionnaire. Results: While there were not any differences between two groups for anxiety and depression scores as well for subgroups, secondary infertile women showed a higher rate of severe depression than primary infertile women (11/60 vs. 10/166). While patients' age was correlated with anxiety score, number of treatment attempts was correlated with depression score.Conclusion: Infertility treatment does not have only physical side effects but it has also a psychological burden for women. While having a child is very important for some cultures it may not decrease the stress of women who started infertility treatment and wanted to have more. It is important to support the women who undergo infertility treatment whether is primary or secondary infertile, while this affects the patient's mood positively as well may increase the success of treatment.

1 March 2019 in Journal of Turkish Society of Obstetric and Gynecology
Verified
Journal Article
Open access
MÖMehmet Özsürmeli
Mehmet Özsürmeli
SBSELIM BUYUKKURT
SELIM BUYUKKURT
MSMete Sucu
Mete Sucu
EAErol Arslan
Erol Arslan
CACıgdem AKCABAY
Cıgdem AKCABAY
CECüneyt Evrüke
Cüneyt Evrüke
To evaluate persistent left superior vena cava (PLSVC) cases according to associated cardiac, extracardiac, and chromosomal anomalies in the prenatal period and to review their outcomes. The data of patients with a prenatal diagnosis of PLSVC between January 2013 and December 2017 were reviewed retrospectively. Data of 32 cases were reviewed. Nineteen (60%) cases were associated with cardiac defects, 5 (15%) were associated with both cardiac and extracardiac defects, and 8 (25%) had no associated anomalies. Two fetuses had karyotype anomalies. All patients with isolated PLSVC survived. Among the cases associated with extracardiac anomalies, cardiac anomalies, and with both extracardiac and cardiac anomalies, the survival rate was 40%, 40%, and 25%, respectively. Outcome was more favorable in cases with isolated PLSVC (100% vs. 40%). Prenatally diagnosed PLSVC is associated with cardiac and extracardiac anomalies in the majority of cases. The prognosis is good in isolated cases, but worsens when accompanied by cardiac or extracardiac anomalies.